- Report
- July 2022
- 317 Pages
Global
From €3137EUR$3,500USD£2,691GBP
- Report
- October 2021
- 306 Pages
Global
From €3361EUR$3,750USD£2,883GBP
- Report
- April 2021
- 377 Pages
Global
From €3580EUR$3,995USD£3,072GBP
- Report
- March 2021
Global
From €3361EUR$3,750USD£2,883GBP
- Report
- June 2025
- 571 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- December 2024
- 175 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- December 2024
- 175 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- September 2024
- 316 Pages
Global
From €3585EUR$4,000USD£3,075GBP
- Report
- September 2024
- 330 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- May 2024
- 277 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- April 2024
- 279 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- January 2023
- 343 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- September 2022
- 175 Pages
Global
From €4481EUR$5,000USD£3,844GBP
- Report
- August 2025
- 182 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 197 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 189 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 191 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 195 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 188 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- August 2025
- 197 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more